U.S. federal trademark · Serial No. 98620766
Pharmaceuticals for the treatment of agitation, namely, an orally-dissolving formulation used for the treatment of agitation associated with alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, or other central nervous system disorders, namely, dementia and depression
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.